Compound 1813
Identifiers
- Canonical SMILES:
CC(=O)c1cccc(c1)-c1c(C)noc1C
- IUPAC name:
1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]ethan-1-one
- InChi:
InChI=1S/C13H13NO2/c1-8-13(10(3)16-14-8)12-6-4-5-11(7-12)9(2)15/h4-7H,1-3H3
- InChiKey:
PQDJCPDVQWLFCE-UHFFFAOYSA-N
External links
![]() 44243549 |
![]() CHEMBL1828980 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
3 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 5.22 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 215.09 g/mol | |||
HBA | 3 | |||
HBD | 0 | |||
HBA + HBD | 3 | |||
AlogP | 1.87 | |||
TPSA | 43.10 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 3 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/jm200640v | 3b | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 4.61 | |
10.1021/jm200640v | 3b | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD2 | pIC50 (half maximal inhibitory concentration, -log10) | 5.22 | |
10.1021/jm200640v | 3b | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen CREBBP | pIC50 (half maximal inhibitory concentration, -log10) | 4.25 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6068 | Valdecoxib | DB00580 | |
0.5290 | Parecoxib | DB08439 | |
0.5089 | Alobresib | DB14970 | |
0.4540 | AUY922 | DB11881 | |
0.4206 | Isocarboxazid | DB01247 | |
0.4118 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE | DB06964 | |
0.4045 | PX-102 | DB15416 | |
0.3980 | 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide | DB06961 | |
0.3855 | 5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID | DB08001 | |
0.3681 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL | DB08715 | |
0.3623 | 3-phenyl-5-(1H-pyrazol-3-yl)isoxazole | DB07613 | |
0.3577 | Leflunomide | DB01097 | |
0.3526 | 6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE | DB07202 | |
0.3451 | Florantyrone | DB08975 | |
0.3333 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL | DB08713 |